Literature DB >> 1917692

The effects of normal aging on the response of the pituitary-gonadal axis to chronic clomiphene administration in men.

J S Tenover1, W J Bremner.   

Abstract

Serum androgens decline with age in normal men, despite normal or elevated bioactive serum gonadotropins, suggesting that primary testicular dysfunction occurs with aging. The authors further assessed the question of age-related testicular dysfunction by evaluating whether raising serum gonadotropins above the normal serum range for an extended time in healthy elderly men might result in bringing their gonadal function to a level similar to that found in young adult men. Five elderly (65 to 85 years old) and five young adult men (26 to 33 years old) were given 50 mg of clomiphene citrate (CC) twice a day for 8 weeks to stimulate gonadotropin production. During that time, testosterone (T), non-sex hormone-binding globulin bound T, and estradiol increased significantly in both age groups, while serum inhibin increased significantly only in the young adult men. The increases in serum androgens with CC administration were significantly greater in the young adult men than in the elderly men. These hormone changes occurred in the setting of serum gonadotropins that increased significantly in both age groups, although there was a tendency for the elderly men to have a smaller increase in luteinizing hormone. Despite 8 weeks of stimulation of the pituitary-gonadal axis by CC administration, the elderly men demonstrated significantly diminished testicular responses compared with the young adult men. Sertoli cell function, as determined by inhibin production, was more diminished in the elderly men than was Leydig cell function. These data strengthen the hypothesis that normal aging in men is accompanied by a decline in testicular function.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1917692

Source DB:  PubMed          Journal:  J Androl        ISSN: 0196-3635


  10 in total

Review 1.  Treatment of hypogonadotropic male hypogonadism: Case-based scenarios.

Authors:  Lindsey E Crosnoe-Shipley; Osama O Elkelany; Cyrus D Rahnema; Edward D Kim
Journal:  World J Nephrol       Date:  2015-05-06

Review 2.  Age-related changes in male gonadal function. Implications for therapy.

Authors:  D Maas; A Jochen; B Lalande
Journal:  Drugs Aging       Date:  1997-07       Impact factor: 3.923

Review 3.  Obesity, type 2 diabetes, and testosterone in ageing men.

Authors:  Gary Wittert; Mathis Grossmann
Journal:  Rev Endocr Metab Disord       Date:  2022-07-14       Impact factor: 9.306

Review 4.  Alternative treatment modalities for the hypogonadal patient.

Authors:  Landon W Trost; Mohit Khera
Journal:  Curr Urol Rep       Date:  2014-07       Impact factor: 3.092

Review 5.  Challenges in Testosterone Measurement, Data Interpretation, and Methodological Appraisal of Interventional Trials.

Authors:  Landon W Trost; John P Mulhall
Journal:  J Sex Med       Date:  2016-05-18       Impact factor: 3.802

Review 6.  Alternatives to testosterone replacement: testosterone restoration.

Authors:  Andrew McCullough
Journal:  Asian J Androl       Date:  2015 Mar-Apr       Impact factor: 3.285

7.  Clomiphene citrate ameliorated lead acetate-induced reproductive toxicity in male Wistar rats.

Authors:  Oyeyemi A Wahab; Anyanwu C Princely; Akinola A Oluwadamilare; Daramola O Ore-Oluwapo; Alli O Blessing; Ehiaghe F Alfred
Journal:  JBRA Assist Reprod       Date:  2019-10-14

8.  The role of clomiphene citrate in late onset male hypogonadism.

Authors:  Carlos Teodósio Da Ros; Lucas Uglione Da Ros; João Pedro Uglione Da Ros
Journal:  Int Braz J Urol       Date:  2022 Sep-Oct       Impact factor: 3.050

Review 9.  Exogenous testosterone: a preventable cause of male infertility.

Authors:  Lindsey E Crosnoe; Ethan Grober; Dana Ohl; Edward D Kim
Journal:  Transl Androl Urol       Date:  2013-06

Review 10.  Is There Room for SERMs or SARMs as Alternative Therapies for Adult Male Hypogonadism?

Authors:  Vito A Giagulli; Andrea Silvestrini; Carmine Bruno; Vincenzo Triggiani; Alvaro Mordente; Antonio Mancini
Journal:  Int J Endocrinol       Date:  2020-01-21       Impact factor: 3.257

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.